Surrogate markers for cerebral blood flow correlate with [18F]-fallypride binding potential at dopamine D2/3 receptors in human striatum

Synapse

Volumn 67, Issue 4, 2013, Pages 199-203

  Cumming, Paul ^a   Xiong, Guoming ^a   Fougère, Christian La ^a   Rominger, Axel ^a   Bartenstein, Peter ^a   Buchholz, Hans Georg ^b   Piel, Markus ^b   Rösch, Frank ^b   Gründer, Gerhard ^c,d   Vernaleken, Ingo ^c,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b Department of Nuclear Medicine ^*  (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d Julich Aachen Research Alliance JARA   (Germany)

Author keywords

18F fallypride; Binding potential; Flow dependence; PET

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FALLYPRIDE F 18; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CAUDATE NUCLEUS; CORPUS STRIATUM; HUMAN; HUMAN EXPERIMENT; IMAGING SYSTEM; NEUROIMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; RETROSPECTIVE STUDY; TEMPORAL LOBE; THALAMUS;

ADOLESCENT; ADULT; BENZAMIDES; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84873995028     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21630     Document Type: Article

References (21)

1. Bertsch K, Hagemann D, Hermes M, Walter C, Khan R, Naumann E. 2009. Resting cerebral blood flow, attention, and aging. Brain Res 1267: 77-88.
2. Cumming P. 2011. Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review. Synapse 65: 892-909.
3. Gallezot J-D, Beaver JD, Gunn RN, Nabulsi N, Weinzimmer D, Singhal T, Slifstein M, Fowles K, Ding Y-S, Huang Y, Laruelle M, Carson RE, Rabiner EA. 2012. Affinity and selectivity of [11C]-({thorn})-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Synapse 66: 489-500.
4. Graff-Guerrero A, Mizrahi R, Agid O, Marcon H, Barsoum P, Rusjan P, Wilson AA, Zipursky R, Kapur S. 2009. The dopamine D2 receptors in high-affinity State and D3 receptors in schizophrenia: A clinical [11C]-(+)-PHNO PET study. Neuropsychopharmacology 34: 1078-1086.
5. Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P. 2006. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology 31: 1027-1035.
6. Hassoun W, Le Cavorsin M, Ginovart N, Zimmer L, Gualda V, Bonnefoi F, Leviel V. 2003. PET study of the [11C]raclopride binding in the striatum of the awake cat: Effects of anaesthetics and role of cerebral blood flow. Eur J Nucl Med Mol Imaging 30: 185-186.
7. Inoue K, Ito H, Shidahara M, Goto R, Kinomura S, Sato K, Taki Y, Okada K, Kaneta T, Fukada H. 2006. Database of normal human cerebral blood flow measured by SPECT: II. Quantification of I-123-IMP studies with ARG method and effects of partial volume correction. Ann Nucl Med 20: 139-146.
8. Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A. 2010. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography. Biol Psychiatry 68: 634-641.
9. la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, Cumming P. 2010. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: Effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage 49: 1406-1415.
10. Lammertsma AA, Hume SP. 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4: 153-158.
11. Liu N, Fu-rong LV, Fa-jin LV, You YF, Sheng B. 2010. Relationship between anatomic structures of the strait sinus proximal end and chronic hydrocephalus with CT angiography. Chin J Med Imaging Technol 26;11: 2103-2106.
12. Mach RH, Ehrenkaufer RL, Greenberg JH, Shao L, Morton TE, Evora PH, Nowak PA, Luedtke RR, Cohen D, Reivich M. 1995. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain. Synapse 19: 177-187.
13. Mukherjee J, Yang Z-Y, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen C-T, Mintzer R, Cooper M. 1999. Preliminary assessment of extrastriatal dopamine d-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl Med Biol 26: 519-527.
14. Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O. 2012. [(18) F]fallypride PET measurement of striatal and extrastriatal dopamine D(2/3) receptor availability in recently abstinent alcoholics. Addict Biol 17;2: 490-503.
15. Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P. 2004. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain. Synapse 15;53: 222-233.
16. Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J, Hackett E, Bae SA, Laruelle M, Abi-Dargham A. 2010. Striatal and extrastriatal dopamine release measured with PET and [18F]fallypride. Synapse 64: 350-362.
17. Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT. 2010. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol. J Cereb Blood Flow Metab 30: 994-1007.
18. Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz H-G, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G. 2008. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: A positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone. J Clin Psychopharmacol 28: 608-617.
19. Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G. 2010. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Int J Neuropsychopharmacol 13: 951-960.
20. Vernaleken I, Peters L, Raptis M, Lin R, Buchholz HG, Zhou Y, Winz O, Rösch F, Bartenstein P, Wong DF, Schäfer WM, Gründer G. 2011. The applicability of SRTM in [(18)F]fallypride PET investigations: Impact of scan durations. J Cereb Blood Flow Metab 31: 1958-1966.
21. Zald DH, Woodward ND, Cowan RL, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Smith CE, Hakyemez H, Li R, Kessler RM. 2010. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding. Neuroimage 51: 53-62.